Trial intelligence / Profile preview

CNS Effects and PK of IV Diphenhydramine

NCT05219604Phase 4Terminated

Sponsor
Dent Neurosciences Research Center, Inc.
Start
Mar 2022
Primary completion
Oct 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of diphenhydramine, sponsored by Dent Neurosciences Research Center, Inc.. Started Mar 2022; status: terminated.

02

Drugs

diphenhydramine

Beyond the preview

Go deeper on NCT05219604.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05219604.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call